KOSDAQ Newly Listed Stocks Experiencing Severe Volatility and Drops Within a Single Day...Investors Need to Pay Attention

Recently listed stocks on the KOSDAQ market experienced a strong upward trend in the short term followed by a sharp decline at closing. Such dramatic stock price fluctuations have sparked controversy among investors.

First, ESTEEM soared nearly four times its offering price on the first day of listing, but on the 23rd, it fell 24.49%, closing at 11,500 won. Analysts believe that ESTEEM’s rapid rise and fall are the result of investors selling off large amounts of shares to cash out. This is a common phenomenon in the KOSDAQ market, where investor psychology focused on short-term arbitrage significantly impacts stock prices more than company performance.

IM Biotech also faced a similar situation. Although it doubled in value after listing, it plummeted 26.83% within just a few trading days. This can be interpreted as: given its core business of pharmaceutical manufacturing, the stock’s surge was driven more by early investor expectations rather than long-term performance support.

Kanaph Therapeutics also opened at twice its offering price on the first day, but subsequently experienced double-digit declines, highlighting market volatility. Such intense fluctuations reflect the reality that newly listed companies are still in the early stages of their business, making their future value difficult to assess.

This market trend indicates that regardless of company performance, stock prices can easily fluctuate due to investor buying and selling behavior. The overall KOSDAQ index has also plummeted 5.56%, showing an unstable trend. Investor psychology is likely to continue exerting a decisive influence on the market, requiring ongoing observation and analysis.